MASTL and cancer: Unsurprisingly, these roles have led to MASTL being identified as a potential oncogenic kinase18 with upregulation and over-expression correlating with poor patient outcomes in a variety of cancer types, including breast19–21, colon22,23 uterine22, head and neck24 and pancreatic cancer25.